D-0578-2023 Class II Ongoing

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0578-2023 was initiated by RemedyRepack Inc. on May 1, 2023 and is designated Class II. Reason for recall: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or… The recall status is ongoing. Affected quantity: 29 x 30-count card, 1 x 100 UD box.

Recall details

Product Type
Drugs
Report Date
May 24, 2023
Initiation Date
May 1, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29 x 30-count card, 1 x 100 UD box

Product description

Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD box, NDC # 70518-2534-00, MFG: Akorn, Lake Forest, IL 60045, Repackaged by : RemedyRepack Inc., PA 15701. Mfg NDC # 61748-0012-01

Reason for recall

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Distribution pattern

Product was distrituded to three direct account in PA.

Code information

Lot: a) B2110254-021423, exp. date 08/17/2023; b) J0684183-022323, exp. date 02/28/2024;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0578-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0578-2023. Report a data issue: hello@regdatalab.com.